Repair blend
GLOW with KPV added — the same repair cascade with a dedicated anti-inflammatory component in front of it.
KLOW is a four-peptide blend: KPV, GHK-Cu, BPC-157, and TB-500. The relationship to GLOW is simple and worth stating plainly — KLOW is GLOW with KPV added. That one addition changes what the blend is good for, because KPV addresses something the other three do not directly target.
The order matters conceptually. KPV quiets the inflammatory signaling first, which changes the environment. TB-500 then mobilizes cells into that environment, BPC-157 builds blood supply and repairs, and GHK-Cu lays down the structural collagen. Repair processes work better in tissue that is not actively inflamed, which is the entire argument for putting KPV in the vial.
KPV inhibits NF-κB nuclear translocation via melanocortin receptor signaling, lowering TNF-α, IL-1β, and IL-6 while raising IL-10 and TGF-β, and strengthens epithelial tight junctions. TB-500 drives actin-mediated cell migration; BPC-157 promotes angiogenesis through VEGF and nitric oxide pathways alongside fibroblast recruitment; GHK-Cu drives collagen I and III, elastin, and glycosaminoglycan expression while suppressing MMPs. All four raise VEGF and recruit fibroblasts, with KPV contributing the anti-inflammatory arm the other three lack.
KPV's contribution is felt earliest — inflammatory changes over hours to days. The repair and structural components follow the same weeks-long timeline as GLOW. If inflammation was genuinely the limiting factor, the early phase tends to be more noticeable than with GLOW alone.
Every page on this site includes this section. If a source only tells you what something does, you are reading marketing.
All the GLOW considerations apply — copper metabolism disorders, and the angiogenesis question for anyone with a cancer history — plus KPV's immune modulation, which makes prescriber involvement more important for anyone with an autoimmune condition or on immunomodulating therapy. None of the four components is FDA- or EMA-approved. Not appropriate during pregnancy or breastfeeding.
Four synthesis processes and a four-way ratio. The certificate of analysis should describe the blend as manufactured. If a supplier cannot produce that, they are selling you confidence rather than verification.
If the situation is inflammation-driven — gut issues, inflammatory skin conditions, an injury that keeps flaring — KLOW is the more appropriate choice. For straightforward repair and cosmetic improvement, GLOW is cleaner and less expensive.
KPV, the component that distinguishes it from GLOW.
There would be no reason to. KLOW contains everything in GLOW.
General education only goes so far. If you want help deciding whether this is relevant to your goals, history, and current labs, schedule a consultation with the Bearing team.
Request a Consultation